ZS Pharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

News

AstraZeneca Seals Three Drug Deals

News

AstraZeneca to buy ZS Pharma for $2.7 billion

Top-Feature

Concept Heidelberg

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

ZS Pharma

Pharma Outlook 2025

AstraZeneca Seals Three Drug Deals

AstraZeneca to buy ZS Pharma for $2.7 billion

Top-Feature

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Europe’s Biotech Inflection Point

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

Anchored in Sustainability

Driving Sustainability Through Collaboration

Leading Transformation

Leading the way. Driving results.

API Manufacturing

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Leading Transformation

Newsletter & e-edition